Furosemide Patent Expiration

Furosemide is Used for treating congestion due to fluid overload in adults with NYHA class II/III chronic heart failure. It was first introduced by Validus Pharmaceuticals Llc in its drug Lasix on Approved Prior to Jan 1, 1982. Other drugs containing Furosemide are Furosemide, Furoscix. 43 different companies have introduced drugs containing Furosemide.


Furosemide Patents

Given below is the list of patents protecting Furosemide, along with the drug name that holds that patent and the company name owning that drug.

Drug Used in Drug Patent Number Drug Patent Title Drug Patent Expiry Drug Owner
Furoscix US10272064 Pharmaceutical formulations for subcutaneous administration of furosemide Apr 03, 2034 Scpharmaceuticals
Furoscix US11433044 Pharmaceutical formulations for subcutaneous administration of furosemide Apr 03, 2034 Scpharmaceuticals
Furoscix US9884039 Pharmaceutical formulations for subcutaneous administration of furosemide Apr 03, 2034 Scpharmaceuticals



Furosemide's Family Patents

Family Patents

Explore Our Curated Drug Screens

Drugs Generating Over $1 Billion in Annual Revenue
Explore the top-performing drugs that dominate the pharmaceutical industry
View List
NCE-1 Patent Expiry in the Next 1 Year
Identify opportunities as new chemical entity (NCE-1) patents approach expiry
View List
Recently Granted Patents in EP
Find the opportunity to file Oppositions
View List

Furosemide Generic API Manufacturers

Several generic applications have been filed for Furosemide. The first generic version for Furosemide was by Igi Laboratories Inc and was approved on Sep 9, 1985. And the latest generic version is by Saba Ilac Sanayive Ticaret As and was approved on Apr 2, 2024.

Given below is the list of companies who have filed for Furosemide generic, along with the locations of their manufacturing plants worldwide.


1. ACCORD HLTHCARE

Accord Healthcare Inc has filed for 1 generic for Furosemide. Given below are the details of the strengths of this generic introduced by Accord Hlthcare.

Strength Dosage Form Availability Application Pathway TE code Launch Date
10MG/ML

injectable Prescription INJECTION AP Dec 15, 1986





2. AMNEAL PHARMS CO

Amneal Pharmaceuticals Co Gmbh has filed for 1 generic for Furosemide. Given below are the details of the strengths of this generic introduced by Amneal Pharms Co.

Strength Dosage Form Availability Application Pathway TE code Launch Date
10MG/ML

injectable Prescription INJECTION AP Jul 20, 2016





3. ANI PHARMS

Ani Pharmaceuticals Inc has filed for 3 different strengths of generic version for Furosemide. Given below are the details of the strengths of this generic introduced by Ani Pharms.

Strength Dosage Form Availability Application Pathway TE code Launch Date
40MG

tablet Discontinued ORAL N/A Feb 26, 1986
20MG

tablet Discontinued ORAL N/A Jan 2, 1987
80MG

tablet Discontinued ORAL N/A Feb 9, 1988





4. AREVA PHARMS

Areva Pharmaceuticals Inc has filed for 1 generic for Furosemide. Given below are the details of the strengths of this generic introduced by Areva Pharms.

Strength Dosage Form Availability Application Pathway TE code Launch Date
10MG/ML

injectable Prescription INJECTION AP Dec 18, 2020





5. ASTRAZENECA

Astrazeneca Lp has filed for 1 generic for Furosemide. Given below are the details of the strengths of this generic introduced by Astrazeneca.

Strength Dosage Form Availability Application Pathway TE code Launch Date
10MG/ML

injectable Discontinued INJECTION N/A Sep 9, 1985


Manufacturing Plant Locations
New

Astrazeneca's manufacturing plants are situated in 5 countries - Sweden, France, Germany, United States, Netherlands. Given below are the details of these plant locations as well as the firm names of Astrazeneca as present at those locations.

Country City Firm Name
Sweden
Sodertalje AstraZeneca AB
France
Dordogne AstraZeneca Dunkerque Production (AZDP)
Germany
Wedel AstraZeneca GmbH
United States
Mount Vernon AstraZeneca Pharmaceuticals LP
Gaithersburg AstraZeneca Pharmaceuticals LP
Redwood City AstraZeneca Pharmaceuticals LP
San Diego AstraZeneca, PLC
Coppell AstraZeneca Pharmaceuticals, LP
Frederick AstraZeneca Pharmaceuticals LP
Westborough AstraZeneca LP
Denver AstraZeneca Pharmaceuticals LP
Wilmington AstraZeneca Pharmaceuticals LP
Newark AstraZeneca Pharmaceuticals, LP
Philadelphia AstraZeneca Pharmaceuticals LP
Netherlands
Nijmegen AstraZeneca Nijmegen B.V.





6. AVET LIFESCIENCES

Avet Lifesciences Ltd has filed for 1 generic for Furosemide. Given below are the details of the strengths of this generic introduced by Avet Lifesciences.

Strength Dosage Form Availability Application Pathway TE code Launch Date
10MG/ML

injectable Prescription INJECTION AP Aug 26, 2014





7. BAXTER HLTHCARE CORP

Baxter Healthcare Corp has filed for 1 generic for Furosemide. Given below are the details of the strengths of this generic introduced by Baxter Hlthcare Corp.

Strength Dosage Form Availability Application Pathway TE code Launch Date
10MG/ML

(reference standard)

injectable Prescription INJECTION AP Jan 27, 2014





8. EUGIA PHARMA

Eugia Pharma Specialities Ltd has filed for 1 generic for Furosemide. Given below are the details of the strengths of this generic introduced by Eugia Pharma.

Strength Dosage Form Availability Application Pathway TE code Launch Date
10MG/ML

injectable Prescription INJECTION AP May 3, 2019


Manufacturing Plant Locations
New

Eugia Pharma's manufacturing plants are situated in 1 country - India. Given below are the details of these plant locations as well as the firm names of Eugia Pharma as present at those locations.

Country City Firm Name
India
Pashamylaram Eugia Pharma Specialities Limited
Riico Industrial Area EUGIA Pharma Specialities Limited
Medchal-Malkajgiri District EUGIA Pharma Specialities Limited





9. GLAND PHARMA LTD

Gland Pharma Ltd has filed for 1 generic for Furosemide. Given below are the details of the strengths of this generic introduced by Gland Pharma Ltd.

Strength Dosage Form Availability Application Pathway TE code Launch Date
10MG/ML

injectable Prescription INJECTION AP Jul 1, 2020





10. GRAVITI PHARMS

Graviti Pharmaceuticals Private Ltd has filed for 3 different strengths of generic version for Furosemide. Given below are the details of the strengths of this generic introduced by Graviti Pharms.

Strength Dosage Form Availability Application Pathway TE code Launch Date
20MG

tablet Prescription ORAL AB Oct 17, 2022
40MG

tablet Prescription ORAL AB Oct 17, 2022
80MG

tablet Prescription ORAL AB Oct 17, 2022





11. HIKMA

Hikma Pharmaceuticals Usa Inc has filed for 3 different strengths of generic version for Furosemide. Given below are the details of the strengths of this generic introduced by Hikma.

Strength Dosage Form Availability Application Pathway TE code Launch Date
80MG

tablet Prescription ORAL AB Jan 24, 1986
40MG/5ML

solution Prescription ORAL N/A Apr 22, 1987
10MG/ML

injectable Discontinued INJECTION N/A Sep 14, 1990


Manufacturing Plant Locations
New

Hikma's manufacturing plants are situated in 3 countries - United States, Portugal, Jordan. Given below are the details of these plant locations as well as the firm names of Hikma as present at those locations.

Country City Firm Name
United States
Eatontown Hikma Pharmaceuticals USA, Inc.
Cherry Hill Hikma Pharmaceuticals USA Inc.
Carlsbad Hikma Cali Inc. DBA Leucadia Pharmaceuticals
Dayton Hikma Injectables USA Inc
Portugal
Terrugem Snt Hikma Farmaceutica, (Portugal) S.A.
Jordan
Amman Hikma Pharmaceuticals LLC





12. HOSPIRA

Hospira Inc has filed for 1 generic for Furosemide. Given below are the details of the strengths of this generic introduced by Hospira.

Strength Dosage Form Availability Application Pathway TE code Launch Date
10MG/ML

injectable Prescription INJECTION AP May 28, 1999


Manufacturing Plant Locations
New

Hospira's manufacturing plants are situated in 3 countries - Australia, United States, Dominican Republic (the). Given below are the details of these plant locations as well as the firm names of Hospira as present at those locations.

Country City Firm Name
Australia
Mulgrave Hospira Australia Pty Ltd.
United States
Clayton Hospira, Inc.
Lake Forest Hospira Inc
Pleasant Prairie Hospira Worldwide, LLC d.b.a. Hospira, a Pfizer-owned Company
Mcpherson Hospira, Inc., A Pfizer Company
Morgan Hill Hospira Inc
Rocky Mount Hospira, Inc.
Dominican Republic (the)
Haina, San Cristobal Hospira, Ltd.





13. IGI LABS INC

Igi Laboratories Inc has filed for 1 generic for Furosemide. Given below are the details of the strengths of this generic introduced by Igi Labs Inc.

Strength Dosage Form Availability Application Pathway TE code Launch Date
10MG/ML

injectable Discontinued INJECTION N/A Sep 9, 1985





14. IPCA LABS LTD

Ipca Laboratories Ltd has filed for 3 different strengths of generic version for Furosemide. Given below are the details of the strengths of this generic introduced by Ipca Labs Ltd.

Strength Dosage Form Availability Application Pathway TE code Launch Date
80MG

tablet Prescription ORAL AB Sep 18, 2006
20MG

tablet Prescription ORAL AB Sep 18, 2006
40MG

tablet Prescription ORAL AB Sep 18, 2006





15. LEADING

Leading Pharma Llc has filed for 3 different strengths of generic version for Furosemide. Given below are the details of the strengths of this generic introduced by Leading.

Strength Dosage Form Availability Application Pathway TE code Launch Date
20MG

tablet Prescription ORAL AB Nov 9, 2005
40MG

tablet Prescription ORAL AB Nov 9, 2005
80MG

tablet Prescription ORAL AB Nov 9, 2005


Manufacturing Plant Locations
New

Leading's manufacturing plants are situated in 1 country - United States. Given below are the details of these plant locations as well as the firm names of Leading as present at those locations.

Country City Firm Name
United States
Fairfield Leading Pharma, LLC
Seattle Leading Edge Jet Center





16. MANKIND PHARMA

Mankind Pharma Ltd has filed for 1 generic for Furosemide. Given below are the details of the strengths of this generic introduced by Mankind Pharma.

Strength Dosage Form Availability Application Pathway TE code Launch Date
10MG/ML

injectable Prescription INJECTION AP Dec 16, 2022


Manufacturing Plant Locations
New

Mankind Pharma's manufacturing plants are situated in 1 country - India. Given below are the details of these plant locations as well as the firm names of Mankind Pharma as present at those locations.

Country City Firm Name
India
Imt Manesar Mankind Pharma Limited
Paonta Sahib Mankind Pharma Limited





17. MARSAM PHARMS LLC

Marsam Pharmaceuticals Llc has filed for 1 generic for Furosemide. Given below are the details of the strengths of this generic introduced by Marsam Pharms Llc.

Strength Dosage Form Availability Application Pathway TE code Launch Date
10MG/ML

injectable Discontinued INJECTION N/A Jun 30, 1994





18. MEITHEAL

Meitheal Pharmaceuticals Inc has filed for 1 generic for Furosemide. Given below are the details of the strengths of this generic introduced by Meitheal.

Strength Dosage Form Availability Application Pathway TE code Launch Date
10MG/ML

injectable Prescription INJECTION AP Jan 27, 2022





19. MYLAN

Mylan Pharmaceuticals Inc has filed for 1 generic for Furosemide. Given below are the details of the strengths of this generic introduced by Mylan.

Strength Dosage Form Availability Application Pathway TE code Launch Date
80MG

tablet Discontinued ORAL N/A Oct 29, 1986


Manufacturing Plant Locations
New

Mylan's manufacturing plants are situated in 4 countries - United States, India, Canada, Ireland. Given below are the details of these plant locations as well as the firm names of Mylan as present at those locations.

Country City Firm Name
United States
Rockford Mylan Institutional, Inc.
Saint Albans Mylan Technologies, Inc.
Santa Barbara Mylandon LLC dba Debbie s Delights Santa Barbara Baking Co.
Morgantown Mylan Specialty, L.P.
Greensboro Mylan Pharmaceuticals Inc
Morgantown MYLAN CONSUMER HEALTHCARE Inc.
San Carlos Mylan Pharmaceuticals Inc.
India
Hyderabad Mylan Laboratories Limited
Bangalore Mylan Laboratories Limited
Hosur Mylan Laboratories Limited
Sarigam Mylan Laboratories Limited
Sinnar Mylan Laboratories Limited
Pithampur, District Dhar Mylan Laboratories Limited
Aurangabad Mylan Laboratories Limited (FDF-2)
Anekal Taluk, Bangalore Mylan Laboratories Limited
Canada
Etobicoke Mylan Pharmaceuticals ULC
Ireland
Inverin Mylan Teoranta





20. PHARMOBEDIENT CNSLTG

Pharmobedient Consulting has filed for 1 generic for Furosemide. Given below are the details of the strengths of this generic introduced by Pharmobedient Cnsltg.

Strength Dosage Form Availability Application Pathway TE code Launch Date
10MG/ML

solution Discontinued ORAL N/A Oct 2, 1987





21. PRINSTON INC

Prinston Pharmaceutical Inc has filed for 3 different strengths of generic version for Furosemide. Given below are the details of the strengths of this generic introduced by Prinston Inc.

Strength Dosage Form Availability Application Pathway TE code Launch Date
40MG

tablet Prescription ORAL AB Mar 26, 2004
20MG

tablet Prescription ORAL AB Mar 26, 2004
80MG

tablet Prescription ORAL AB Mar 26, 2004





22. SABA ILAC SANAYIVE

Saba Ilac Sanayive Ticaret As has filed for 1 generic for Furosemide. Given below are the details of the strengths of this generic introduced by Saba Ilac Sanayive.

Strength Dosage Form Availability Application Pathway TE code Launch Date
10MG/ML

injectable Prescription INJECTION AP Apr 2, 2024





23. SAGENT

Sagent Pharmaceuticals has filed for 1 generic for Furosemide. Given below are the details of the strengths of this generic introduced by Sagent.

Strength Dosage Form Availability Application Pathway TE code Launch Date
10MG/ML

injectable Prescription INJECTION AP Jan 27, 2021


Manufacturing Plant Locations
New

Sagent's manufacturing plants are situated in 1 country - United States. Given below are the details of these plant locations as well as the firm names of Sagent as present at those locations.

Country City Firm Name
United States
Schaumburg Sagent Pharmaceuticals





24. SMITH AND NEPHEW

Smith And Nephew Solopak Div Smith And Nephew has filed for 1 generic for Furosemide. Given below are the details of the strengths of this generic introduced by Smith And Nephew.

Strength Dosage Form Availability Application Pathway TE code Launch Date
10MG/ML

injectable Discontinued INJECTION N/A Feb 5, 1986


Manufacturing Plant Locations
New

Smith And Nephew's manufacturing plants are situated in 1 country - United States. Given below are the details of these plant locations as well as the firm names of Smith And Nephew as present at those locations.

Country City Firm Name
United States
Goodlettsville Smith and Nephew





25. SUN PHARM INDS INC

Sun Pharmaceutical Industries Inc has filed for 3 different strengths of generic version for Furosemide. Given below are the details of the strengths of this generic introduced by Sun Pharm Inds Inc.

Strength Dosage Form Availability Application Pathway TE code Launch Date
20MG

tablet Discontinued ORAL N/A Apr 1, 2014
40MG

tablet Discontinued ORAL N/A Apr 1, 2014
80MG

tablet Discontinued ORAL N/A Apr 1, 2014





26. SUN PHARM INDUSTRIES

Sun Pharmaceutical Industries Inc has filed for 2 different strengths of generic version for Furosemide. Given below are the details of the strengths of this generic introduced by Sun Pharm Industries.

Strength Dosage Form Availability Application Pathway TE code Launch Date
20MG

tablet Discontinued ORAL N/A Sep 26, 1985
80MG

tablet Discontinued ORAL N/A Jan 26, 1988





27. WATSON LABS

Watson Laboratories Inc has filed for 3 different strengths of generic version for Furosemide. Given below are the details of the strengths of this generic introduced by Watson Labs.

Strength Dosage Form Availability Application Pathway TE code Launch Date
40MG

tablet Discontinued ORAL N/A Nov 22, 1985
20MG

tablet Discontinued ORAL N/A Feb 26, 1986
10MG/ML

injectable Discontinued INJECTION N/A Jan 2, 1987





28. WATSON LABS TEVA

Watson Laboratories Inc An Indirect Wholly Owned Sub Of Teva Pharmaceuticals Usa Inc has filed for 2 different strengths of generic version for Furosemide. Given below are the details of the strengths of this generic introduced by Watson Labs Teva.

Strength Dosage Form Availability Application Pathway TE code Launch Date
20MG

tablet Discontinued ORAL N/A Nov 22, 1985
80MG

tablet Discontinued ORAL N/A Jan 7, 1986





29. WOCKHARDT

Wockhardt Ltd has filed for 1 generic for Furosemide. Given below are the details of the strengths of this generic introduced by Wockhardt.

Strength Dosage Form Availability Application Pathway TE code Launch Date
10MG/ML

injectable Prescription INJECTION AP Mar 22, 2007


Manufacturing Plant Locations
New

Wockhardt's manufacturing plants are situated in 1 country - India. Given below are the details of these plant locations as well as the firm names of Wockhardt as present at those locations.

Country City Firm Name
India
Aurangabad Wockhardt Limited
Solan, Nalagarh Wockhardt Limited - Baddi
Ankleshwar Wockhardt, Ltd.